JP2024523466A5 - - Google Patents
Info
- Publication number
- JP2024523466A5 JP2024523466A5 JP2023578896A JP2023578896A JP2024523466A5 JP 2024523466 A5 JP2024523466 A5 JP 2024523466A5 JP 2023578896 A JP2023578896 A JP 2023578896A JP 2023578896 A JP2023578896 A JP 2023578896A JP 2024523466 A5 JP2024523466 A5 JP 2024523466A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- positions
- chain
- antisense
- sense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163213506P | 2021-06-22 | 2021-06-22 | |
| US63/213,506 | 2021-06-22 | ||
| US202263331563P | 2022-04-15 | 2022-04-15 | |
| US63/331,563 | 2022-04-15 | ||
| PCT/US2022/034297 WO2022271666A1 (en) | 2021-06-22 | 2022-06-21 | OLIGONUCLEOTIDES FOR IFN-γ SIGNALING PATHWAY MODULATION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523466A JP2024523466A (ja) | 2024-06-28 |
| JP2024523466A5 true JP2024523466A5 (cg-RX-API-DMAC7.html) | 2025-07-01 |
Family
ID=84544753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578896A Pending JP2024523466A (ja) | 2021-06-22 | 2022-06-21 | IFN-γシグナル伝達経路の調節のためのオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240287514A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4359537A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523466A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240040724A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022298641A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223577A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022271666A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021002440A2 (pt) | 2018-08-10 | 2021-05-04 | University Of Massachusetts | oligonucleotídeos modificados visando snps |
| CA3174079A1 (en) | 2020-05-26 | 2021-12-02 | Anastasia Khvorova | Synthetic oligonucleotides having regions of block and cluster modifications |
| AU2024231771A1 (en) * | 2023-03-03 | 2025-08-28 | Royal Institution For The Advancement Of Learning/Mcgill University | Dendritic conjugates for the skin delivery of therapeutic oligonucleotides |
| KR20260026070A (ko) * | 2023-06-16 | 2026-02-25 | 에프. 호프만-라 로슈 아게 | Jak1 발현 조절을 위한 이중 가닥 올리고뉴클레오티드 |
| WO2026131801A1 (en) * | 2024-12-17 | 2026-06-25 | F. Hoffmann-La Roche Ag | Double stranded oligonucleotide for modulating jak1 expression |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998002558A2 (en) * | 1996-07-17 | 1998-01-22 | University Of Medicine And Dentistry Of New Jersey | Chimeric receptors for jak-stat signal transduction |
| US6566132B1 (en) * | 2001-04-26 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of Interferon gamma receptor 1 expression |
| AU2003209340A1 (en) * | 2002-01-18 | 2003-09-02 | Bristol-Myers Squibb Company | Predictor sets for tyrosine kinase pathways |
| EP2305813A3 (en) * | 2002-11-14 | 2012-03-28 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| US20070087344A1 (en) * | 2003-04-23 | 2007-04-19 | Bioseek, Inc. | Methods for characterizing signaling pathways and compounds that interact therewith |
| WO2006094293A2 (en) * | 2005-03-03 | 2006-09-08 | President And Fellows Of Harvard College | Slim compositions and methods of use thereof |
| US20100247580A1 (en) * | 2007-11-30 | 2010-09-30 | Thierry Coche | Method for Classifying Cancer Patients as Responder or Non-Responder to Immunotherapy |
| JP2014501097A (ja) * | 2009-07-06 | 2014-01-20 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | 生物由来物質の産生を高めるための組成物及び方法 |
| CN107012149A (zh) * | 2010-11-19 | 2017-08-04 | 艾德拉药物股份有限公司 | 调控基于toll‑样受体的免疫应答的免疫调节寡核苷酸(iro)化合物 |
| BR112013029340A2 (pt) * | 2011-05-16 | 2017-02-07 | Council Scient Ind Res | método para modular um processo de pigmentação nos melanócitos da pele |
| CN104540946A (zh) * | 2012-05-16 | 2015-04-22 | Rana医疗有限公司 | 用于调节utrn表达的组合物和方法 |
| CA3133241A1 (en) * | 2019-03-15 | 2020-09-24 | University Of Massachusetts | Oligonucleotides for tissue specific apoe modulation |
| FR3098712A1 (fr) * | 2019-07-15 | 2021-01-22 | Commissariat à l'énergie atomique et aux énergies alternatives | Séquences siARN ciblant l'expression des gènes JAK1 ou JAK3 humains pour une utilisation thérapeutique |
-
2022
- 2022-06-21 WO PCT/US2022/034297 patent/WO2022271666A1/en not_active Ceased
- 2022-06-21 KR KR1020247000555A patent/KR20240040724A/ko active Pending
- 2022-06-21 EP EP22829131.6A patent/EP4359537A4/en active Pending
- 2022-06-21 JP JP2023578896A patent/JP2024523466A/ja active Pending
- 2022-06-21 CA CA3223577A patent/CA3223577A1/en active Pending
- 2022-06-21 AU AU2022298641A patent/AU2022298641A1/en active Pending
-
2023
- 2023-12-21 US US18/393,044 patent/US20240287514A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533804A5 (cg-RX-API-DMAC7.html) | ||
| JP2023522701A5 (cg-RX-API-DMAC7.html) | ||
| JP7129702B2 (ja) | オーバーハングを有する二本鎖核酸複合体 | |
| JP2022528487A5 (cg-RX-API-DMAC7.html) | ||
| JP2023518439A5 (cg-RX-API-DMAC7.html) | ||
| JP2023550485A5 (cg-RX-API-DMAC7.html) | ||
| JP2019503394A5 (cg-RX-API-DMAC7.html) | ||
| JP2022525208A5 (cg-RX-API-DMAC7.html) | ||
| JP2021533762A5 (cg-RX-API-DMAC7.html) | ||
| AU2025201455A1 (en) | Chiral control | |
| EP3359523A2 (en) | Oligonucleotide compositions and methods thereof | |
| JP2023518268A5 (cg-RX-API-DMAC7.html) | ||
| JPH09510714A (ja) | オリゴヌクレオチドn3’→p5’ホスホルアミデート:合成および化合物;ハイブリダイゼーションおよびヌクレアーゼ耐性特性 | |
| KR20020033744A (ko) | 사람 eg5의 발현을 억제하는 올리고뉴클레오티드 | |
| CN105121452A (zh) | 三环核苷和由其制备的寡聚化合物 | |
| CN104321334A (zh) | 三环核苷及由其制备的低聚化合物 | |
| JP2025156522A (ja) | 修飾ヘテロ核酸 | |
| EP2781523A1 (en) | Lipophilic oligonucleotide analogs | |
| JP7737667B2 (ja) | 核酸複合体 | |
| JP6882735B2 (ja) | 構造強化されたmiRNA阻害剤S−TuD | |
| WO2024040041A1 (en) | Regulation of activity of rnai molecules | |
| CA2609365C (en) | Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina | |
| EP4426839A1 (en) | Lipid conjugation for targeting astrocytes of the central nervous system | |
| EP4426432A1 (en) | Lipid conjugation for targeting oligodendrocytes of the central nervous system | |
| JP6934695B2 (ja) | 核酸医薬とその使用 |